Leadership is shaped by experience, resilience and the drive to create change. Learn how the journeys of three Women Empowered (WE) employee resource group leaders reflect the spirit of Women’s History Month and International Women’s Day — honoring the past, inspiring the present, and shaping the future. https://bit.ly/3DsOn1d
About us
Welcome to the official LinkedIn page for McKesson Corporation. We're an impact-driven healthcare organization dedicated to “Advancing Health Outcomes For All.” As a global healthcare company, we touch virtually every aspect of health. Our leaders empower our people to lead with a growth mindset and deliver excellence for our customers, partners, and the wellbeing of people, everywhere. We work with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services that make quality care more accessible and affordable. Delivering better health outcomes for our employees, our communities, and our environment. Every day, we strive to inspire and enable people to reach their full potential. To learn more about how #TeamMckesson helps improve care in every setting, visit: https://bit.ly/3xadvB0
- Website
-
https://bit.ly/3xadvB0
External link for McKesson
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Irving, Texas
- Type
- Public Company
- Specialties
- Pharmaceutical Distribution, HealthCare IT, Practice Management, Supply Chain Management, Medication Adherence, Pharmacy Management, Medical Supplies, Oncology Medicine, and Pharmacy Technology
Locations
Employees at McKesson
-
Daniel Tedesco
Managing Principal Counsel, Artificial Intelligence, Enterprise Technology & Sourcing Transactions at McKesson
-
Mark Haynes
Email Marketing Specialist
-
Cassandra L. Wilson
Program Manager - Radiation Value-Based Care at McKesson
-
David Smith, MBA
Senior Internal Auditor SOX McKesson
Updates
-
Across the healthcare industry, one of the most difficult challenges to navigate is #drugshortages. Shortages can occur for several reasons, potentially interrupting essential #oncologycare for patients. In the season premiere of NCODA’s The PQI Podcast, Jessica White discusses how to maintain #supplychain stability, ensuring thousands of cancer patients receive uninterrupted care. Listen to the full episode below.
Season 8 of The PQI Podcast is here, and we’re kicking things off with a crucial topic impacting healthcare systems everywhere: drug shortages. In this premiere episode, Jessica White, PharmD, VP of Specialty Portfolio & Programs at McKesson, shares her unique insights on strategies to navigate drug shortages and ensure continuity of care. Streaming now on your favorite podcast platforms and at: https://lnkd.in/ghbfxT8X
-
Three of our health system leaders, Prateek Bhatia, PhD, MBA, vice president and general manager for Intrafusion by McKesson, Lindsey Smith DeMarrais, managing pharmacist consultant, and Chris Wahlenmaier, MBA, senior director of marketing, recently attended Becker's Healthcare’s 12th Annual CEO+CFO Roundtable and facilitated a discussion with health system leaders on strategic approaches to delivering specialty and infusion services. Read the full article to learn more about their key takeaways. https://lnkd.in/gBDyEedH
-
Across our businesses, we’re committed to always advancing healthcare forward so more patients get the care they need. Leveraging AI and advanced technologies, we provide crucial data and analytics to accelerate oncology drug development, exemplified by Ontada's use of Microsoft Azure AI to efficiently process over 150 million unstructured oncology documents. This speeds up drug development and decision-making, ultimately improving cancer patient care.
Every data point can make a life-changing difference for cancer patients. Ontada, a McKesson business based in Boston, is using Azure AI Foundry and Azure OpenAI Service to unlock insights from 150 million unstructured oncology documents, delivering more robust data faster, and accelerating treatment development. Faster insights mean faster breakthroughs for those who need them most. 💙
-
RxOwnership is committed to empowering independent pharmacy owners by providing essential tools, resources, and insights. This support helps them navigate the evolving world of pharmacy ownership and succeed within their communities. Learn more: https://lnkd.in/gGJi5JiC
-
We are proud to announce our participation in the pilot launch of Angels for Change Project GOLD (Generic Oncology Lifesaving Drugs), a program aimed at ensuring that oncology patients receive uninterrupted access to lifesaving therapies. This is a pivotal step in our purpose of advancing health outcomes for all. Read more: https://lnkd.in/gihCTjiN
-
In our latest eBook, Katya Hall provides insights into how we are leveraging #AI to transform the business of pharmacy, including forecasting and #supplychain management, customer service and patient outcomes through clinical trials. Download the full eBook to learn how we are harnessing data to provide health systems and suppliers with actionable intelligence. https://lnkd.in/gduWjsVE
-
As the use of biosimilars continues to grow within the healthcare industry, it’s important to understand and implement best practices to ensure successful and smooth integration. In a recent Pharmacy Times article, Derek Burns, Pharm.D., MBA, BCPS, BCSCP and Lisa Lasita highlight key operational, clinical and reimbursement insights to consider when integrating biosimilars into practices, specifically for retina and neurology. Read the article here: https://lnkd.in/gQf6Q2Z6
-
Biologics by McKesson is our specialty pharmacy business that specializes in cancer and rare disease areas with the goal of simplifying access to therapies. We have What it Takes to deliver personalized care so patients understand how to take medications, manage side effects and achieve the best possible outcomes. Learn more: https://bit.ly/3EErc4x
Affiliated pages
Similar pages
Browse jobs
Stock
MCK
NYSE
20 minutes delay
$659.61
15.39 (2.389%)
- Open
- 641.98
- Low
- 633.53
- High
- 661.5
Data from Refinitiv
See more info on